Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
COVID-19 Patient Resource Center
Clinical Trials
Search Clinical Trials
Patient Notification System
What is Clinical Research?
Volunteering for a Clinical Trial
Understanding Informed Consent
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Clinical Trial Listings
Market Research
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
JobWatch
White Papers
SOPs
eCFR and Guidances
White Papers
Trial Listings
Advertise
COVID-19
iConnect
Sign In
Create Account
Sign Out
My Account
Home
» FDA Guidance Signals Clear Support for Efforts to Increase Trial Diversity
Looking to read the full article? Subscribe today!
FDA Guidance Signals Clear Support for Efforts to Increase Trial Diversity
December 8, 2020
Upcoming Events
15
Sep
Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis
21
Sep
The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval
16
Oct
WCG MAGI's Clinical Research Conference 2022 West
16
Nov
17th Annual FDA Inspections Summit
Featured Products
Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Featured Stories
Cancer Patients Signal Interest in Less Travel, More Remote Trial Options
New Study Shows Trends in Funding, Racial Balance Amidst COVID-19
Rising Trial Complexities Create More Payment Problems, Frustrations for Sites
BYOD Trials Growing in Popularity, But Unique Tech Challenges Remain
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here
